(Q33401343)

26 July 2017

title

Formation of immune complexes and thrombotic microangiopathy after intravitreal injection of bevacizumab in the primate eye. (English)

1 reference

26 July 2017

1 reference

Ulrich Schraermeyer

1

1 reference

26 July 2017

Sylvie Julien

series ordinal

2

1 reference

26 July 2017

publication date

22 May 2012

1 reference

Graefe's Archive for Clinical and Experimental Ophthalmology

26 July 2017

published in

1 reference

26 July 2017

volume

250

1 reference

26 July 2017

issue

9

1 reference

26 July 2017

page(s)

1303-1313

1 reference

A new weapon for attacking tumor blood vessels

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00417-012-2055-Z

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-012-2055-Z

Reversible posterior leukoencephalopathy syndrome in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-012-2055-Z

The Proportion of Patients with Metastatic Non-small Cell Lung Cancer Potentially Eligible for Treatment with Bevacizumab: A Single Institutional Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-012-2055-Z

VEGF inhibition and renal thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-012-2055-Z

Bevacizumab (Avastin) for the treatment of ocular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-012-2055-Z

Penetration of bevacizumab through the retina after intravitreal injection in the monkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-012-2055-Z

Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-012-2055-Z

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-012-2055-Z

Arterial thromboembolic events in patients with exudative age-related macular degeneration treated with intravitreal bevacizumab or ranibizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-012-2055-Z

Characterization and allelic polymorphisms of rhesus macaque (Macaca mulatta) IgG Fc receptor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-012-2055-Z

The multifunctional choroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-012-2055-Z

Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-012-2055-Z

Lipofuscin can be eliminated from the retinal pigment epithelium of monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-012-2055-Z

IgM anti-Fc gamma R autoantibodies trigger neutrophil degranulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-012-2055-Z

The effect of intravitreal injection of bevacizumab on retinal circulation in patients with neovascular macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-012-2055-Z

Retinal artery occlusion following intravitreal anti-VEGF therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-012-2055-Z

Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab

21 January 2018

1 reference

12 December 2020

Effect of intravitreal bevacizumab on retrobulbar blood flow in injected and uninjected fellow eyes of patients with neovascular age-related macular degeneration

1 reference

12 December 2020

The identification of platelets and platelet antigens in histological sections

1 reference

12 December 2020

Intravitreal anti-VEGF therapy for neovascular age-related macular degeneration and the risk of stroke

1 reference

12 December 2020

The effect of intravitreal bevacizumab (avastin) administration on systemic hypertension

1 reference

12 December 2020

The effect of intravitreal bevacizumab (Avastin) injection on retinal blood flow velocity in patients with choroidal neovascularization

1 reference

12 December 2020

The proportion of patients with metastatic non-small cell lung cancer potentially eligible for treatment with bevacizumab: a single institutional survey.

1 reference

12 December 2020

Platelet ultrastructure and secretion in acute ischemic stroke

1 reference

12 December 2020

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.

1 reference

12 December 2020

10.1007/S00417-012-2055-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

1032184773

0 references

1 reference